Online Educational Activity

The Gout Clinical Companion: The Latest Evidence and Patient Support Tools for the Primary Care Physician

Needs Statement/Intended Audience

This activity has been planned in accordance with the need to provide primary care and family physicians with a continuing medical education activity that addresses ongoing complex issues with the diagnosis and treatment of patients with gout.

Educational Activity Learning Objectives

Upon completion of this course, the participants should be able to:

• Describe the factors to be considered in the diagnosis of gout
• Describe current and emerging gout therapies, including their use at different disease stages and appropriate monitoring practices
• Assess comorbidities and concomitant medications that may necessitate changes in gout management
• Utilize patient education and counseling tools to support patient adherence to gout pharmacotherapy

Credit Statement

The France Foundation designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Faculty

Arthur L. Weaver, MD, MS, FACP, MACR (Chair)
Clinical Professor Medicine Emeritus
Department of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

N. Lawrence Edwards, MD
Professor of Medicine and Vice Chairman
Department of Medicine
University of Florida

Program Director
Department of Medicine
Shands Hospital
Gainesville, Florida

Lee S. Simon, MD
Consultant, Rheumatology/Internal Medicine
SDG LLC
Cambridge, Massachusetts

Commercial Support Acknowledgment

This program is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.